Results 221 to 230 of about 20,699 (254)
The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries [PDF]
The aim of the study was to develop a European list of potentially inappropriate medications (PIM) for older people, which can be used for the analysis and comparison of prescribing patterns across European countries and for clinical practice.A preliminary PIM list was developed, based on the German PRISCUS list of potentially inappropriate medications
Anna Renom-Guiteras, Gabriele Meyer
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Potentially inappropriate medications in the elderly: a French consensus panel list
European Journal of Clinical Pharmacology, 2007To evaluate drug-related problems in the elderly, various lists of potentially inappropriate medications have been published in North America. Unfortunately, these lists are hardly applicable in France. The purpose of this study was to establish a list of inappropriate medications for French elderly using the Delphi method.A two-round Delphi method was
Marie-Laure, Laroche +2 more
openaire +2 more sources
An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list [PDF]
As people get older, their sensitivity to drugs and adverse drug reactions can increase due to pharmacokinetic and pharmacodynamic changes. Older people with dementia are a particularly vulnerable group of people. They are at an increased risk of being prescribed potentially inappropriate medications, which may lead to harmful consequences.
Eva Sönnerstam +2 more
exaly +4 more sources
Potentially inappropriate medication in geriatric patients: the Austrian consensus panel list
Wiener klinische Wochenschrift, 2011The practice of inappropriate medication and drug prescription is a major risk factor for adverse drug reactions in geriatric patients and increases the individual, as well as overall, rates of hospital admissions, resulting in increased health care expenditures.
Eva, Mann +8 more
openaire +2 more sources
Development of a German list of potentially inappropriate medication in the elderly
200916.
Holt, S, Schmiedl, S, Thürmann, PA
openaire +1 more source
[Potentially inappropriate medications in the elderly: a list adapted to French medical practice].
La Revue de medecine interne, 2009Drug induced adverse effects are frequently encountered in geriatrics. Their occurrence can be limited by an adapted prescription. Potentially inappropriate medications are drugs with an unfavourable benefit to risk ratio when other safer or more efficient therapeutic alternatives are available. An expert consensus allowed us to establish a new list of
M-L, Laroche +3 more
openaire +1 more source
Age and ageing
With a growing older population and an increasing prevalence of age-related health conditions, inappropriate prescription (IP) has become a concern in public health. Potentially Inappropriate Medication (PIM) lists were developed to address issues related to IP in the older population.Systematically compare the approaches adopted to develop PIM lists ...
Omar, Ammous +3 more
openaire +4 more sources
With a growing older population and an increasing prevalence of age-related health conditions, inappropriate prescription (IP) has become a concern in public health. Potentially Inappropriate Medication (PIM) lists were developed to address issues related to IP in the older population.Systematically compare the approaches adopted to develop PIM lists ...
Omar, Ammous +3 more
openaire +4 more sources
European Journal of Clinical Pharmacology, 2015
Inappropriate prescribing puts older adults (≥65 years) at risk for adverse drug reactions [1]. Recently, a European list of potentially inappropriate medications (PIMs) was developed, the EU(7)-PIM list [2]. Experts from the seven participating countries (EE, NL, FI, ES, FR, SE, DE) screened their medication market for PIMs, using existing lists of ...
Maarten, Wauters +3 more
openaire +2 more sources
Inappropriate prescribing puts older adults (≥65 years) at risk for adverse drug reactions [1]. Recently, a European list of potentially inappropriate medications (PIMs) was developed, the EU(7)-PIM list [2]. Experts from the seven participating countries (EE, NL, FI, ES, FR, SE, DE) screened their medication market for PIMs, using existing lists of ...
Maarten, Wauters +3 more
openaire +2 more sources
European Journal of Clinical Pharmacology, 2016
From 12 to 14 June 2014, an international multidisciplinary team of experts assembled in Ghent, Belgium, for a European Science Foundation (ESF) exploratory workshop, focusing on the quality of pharmacotherapy in old age. Pharmacotherapy in old age needs to be appraised in the context of ageing, taking into account the importance of multimorbidity ...
Majda, Azermai +2 more
openaire +2 more sources
From 12 to 14 June 2014, an international multidisciplinary team of experts assembled in Ghent, Belgium, for a European Science Foundation (ESF) exploratory workshop, focusing on the quality of pharmacotherapy in old age. Pharmacotherapy in old age needs to be appraised in the context of ageing, taking into account the importance of multimorbidity ...
Majda, Azermai +2 more
openaire +2 more sources
Pharmacoepidemiology and Drug Safety, 2013
ABSTRACTPurposeThe aim of this study was to estimate the prevalence of potentially inappropriate medication (PIM) in the elderly as indicated by Germany's recently published list (PRISCUS) and to assess factors independently associated with PIM prescribing, both overall and separately for therapeutic groups.MethodsClaims data analysis (Health Insurance
Ingrid, Schubert +3 more
openaire +2 more sources
ABSTRACTPurposeThe aim of this study was to estimate the prevalence of potentially inappropriate medication (PIM) in the elderly as indicated by Germany's recently published list (PRISCUS) and to assess factors independently associated with PIM prescribing, both overall and separately for therapeutic groups.MethodsClaims data analysis (Health Insurance
Ingrid, Schubert +3 more
openaire +2 more sources

